4-Tert-butyl-n-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide
正在补全数据,稍后刷新页面可查看最新内容
150727-06-3COc1ccccc1Oc1c(Cl)nc(-c2ncccn2)nc1NS(=O)(=O)c1ccc(C(C)(C)C)cc1XKISWHVJIZSPSC-UHFFFAOYSA-N安全信息仅供参考,不能替代供应商安全技术说明书(SDS)、适用法规与专业评估。
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
生产方法在装有机械搅拌器、温度计、回流冷凝器、滴液漏斗和加热套的烧瓶中,加入4,6-二氯-5-(2-甲氧基苯氧基)-2,2'-联嘧啶(105 g)和4-(叔丁基)苯磺酰胺(64.1 g,0.30 mol)的DMSO(525 mL)溶液。向该悬浮液中加入碳酸钾(83 g,0.60 mol)。在搅拌下将反应混合物加热至100-105℃,维持3-4小时。反应进程通过HPLC监测。反应完成后,将溶液冷却至20-25℃。在10-15分钟内缓慢滴加水(875 mL),继续搅拌1小时。过滤收集沉淀的固体,用水(2×350 mL)洗涤,随后转移至研钵中。加入水(800 mL)和浓盐酸(50 mL),搅拌30分钟。再次过滤收集沉淀的固体,依次用水(2×200 mL)和丙酮(2×175 mL)洗涤。将固体在40±2℃下减压干燥16-24小时,得到乳白色固体产物N-[6-氯-5-(2-甲氧基苯氧基)[2,2'-二嘧啶]-4-基]-4-叔丁基苯磺酰胺,产量为157.8-158.7 g(产率100%)。参考文献:[1] Organic Process Research and Development, 2011, vol. 15, # 6, p. 1382 - 1387[2] Patent: WO2014/104904, 2014, A1. Location in patent: Page/Page column 13; 14[3] Organic Process Research and Development, 2013, vol. 17, # 8, p. 1021 - 1026[4] Patent: WO2012/73135, 2012, A1. Location in patent: Page/Page column 10[5] Patent: WO2013/57545, 2013, A1. Location in patent: Paragraph 15
150727-06-3DTXSID80456425